Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Dividends Score | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $4.56B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| TGTX | TG THERAPEUTICS INC | $2.50B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| SRPT | SAREPTA THERAPEUTICS INC | $12.63B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| VNDA | VANDA PHARMACEUTICALS INC | $280.78M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CORT | CORCEPT THERAPEUTICS INC | $2.55B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| GMAB | GENMAB A | $19.65B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.79B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.65B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| HALO | HALOZYME THERAPEUTICS INC | $5.06B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| INCY | INCYTE CORP | $12.07B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| RPRX | ROYALTY PHARMA PLC | $16.97B | 1.41% | 23.60% | $0.2000 | $0.40 | 28% | 0 | |||
| AMLX | AMYLYX PHARMACEUTICALS INC | $137.60M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| EXEL | EXELIXIS INC | $6.38B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.93B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| TECH | BIO-TECHNE CORP | $12.15B | 0.41% | 22.70% | $0.0800 | $0.32 | 6% | 1 | 2024-05-10 | 2024-05-24 | |
| PBYI | PUMA BIOTECHNOLOGY INC | $234.44M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| BNTX | BIONTECH SE | $22.04B | N/A | 0.00% | $2.1110 | N/A | N/A | 0 | |||
| MDXG | MIMEDX GROUP INC | $1.09B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.73B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| NVO | NOVO NORDISK A S | $554.96B | 1.11% | 47.80% | $0.9299 | $1.37 | 20% | 9 | |||
| REGN | REGENERON PHARMACEUTICALS INC | $105.45B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| UTHR | UNITED THERAPEUTICS CORP | $11.64B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $103.60B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.